Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-036688

General Counsel sold 75,364 shares at $3.40 ($256,464)

From the SEC's structured data for this filing

Trades in this filing

Wilson Martin · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-11 Sale : show line 1 in the form −75,364 $3.40 $256,464 598,489 D
Open-market sales · 75,364 sh · avg $3.40 · $256,464
Loading xslF345X06/form4.xml…